mRNA vaccine triggers fierce immune response to fight malignant brain tumor

In a first-ever human clinical trial of four adult patients, an mRNA cancer vaccine developed at UF quickly reprogrammed the immune system to attack glioblastoma, the most aggressive and lethal brain tumor.